Compounds > n-(3-(aminomethyl)benzyl)acetamidine

n-(3-(aminomethyl)benzyl)acetamidine and camptothecin

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with camptothecin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anichini, A; Bersani, I; Molla, A; Piris, A; Scarito, A; Vegetti, C; Zanon, M	1

Other Studies

1 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and camptothecin

Article	Year
Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents. Cancer research, 2004, Oct-15, Volume: 64, Issue:20 Topics: Amidines; Antineoplastic Agents; Apoptosis; Apoptotic Protease-Activating Factor 1; Benzylamines; Camptothecin; Caspase 9; Caspase Inhibitors; Caspases; Celecoxib; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Humans; Immunohistochemistry; Melanoma; Protein Biosynthesis; Proteins; Pyrazoles; RNA, Messenger; Sulfonamides	2004

Article

Year

Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents.

Cancer research, 2004, Oct-15, Volume: 64, Issue:20

Topics: Amidines; Antineoplastic Agents; Apoptosis; Apoptotic Protease-Activating Factor 1; Benzylamines; Camptothecin; Caspase 9; Caspase Inhibitors; Caspases; Celecoxib; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Humans; Immunohistochemistry; Melanoma; Protein Biosynthesis; Proteins; Pyrazoles; RNA, Messenger; Sulfonamides

2004